✦ LIBER ✦

Immunotherapy of Lung Adenocarcinoma Patient with Peptide-Pulsed Dendritic Cells: a Case Report

✍ Scribed by Kamila Wojas-Krawczyk; Paweł Krawczyk; Jarosław Buczkowski; Anna Walkowska; Olga Jankowska; Elżbieta Czekajska-Chehab; Janusz Milanowski

Book ID: 105751243
Publisher: Springer
Year: 2011
Tongue: English
Weight: 702 KB
Volume: 60
Category: Article
ISSN: 0004-069X
DOI: 10.1007/s00005-011-0157-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vaccination of melanoma patients with pe

Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells

✍ Nestle, Frank O.; Alijagic, Selma; Gilliet, Michel; Sun, Yuansheng; Grabbe, Step 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 926 KB

Immunotherapy of spontaneous metastatic

Immunotherapy of spontaneous metastatic lung cancer with tumor antigen-pulsed, interleukin-12 gene-modified dendritic cells

✍ Ji-quan Chen; Qing-yu Xiu; Ze-min Yan; Wen-tong Luo 📂 Article 📅 2003 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 591 KB

Immunotherapy of solid cancer using dend

Immunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen

✍ Tsuyoshi Itoh, Yuji Ueda, Ichiro Kawashima, Ikuei Nukaya, Hitoshi Fujiwara, Nobu 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 130 KB

Metastasis to the penis in a patient wit

Metastasis to the penis in a patient with adenocarcinoma of lung, case report and literature review

✍ Fu-fu Zheng; Zhong-yun Zhang; Yu-ping Dai; Yue-you Liang; Chun-hua Deng; Yu Tao 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 305 KB

Vaccination with p53-peptide–pulsed dend

Vaccination with p53-peptide–pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study

✍ IngeMarie Svane; AndersE. Pedersen; HansE. Johnsen; Dorte Nielsen; Claus Kamby; 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 443 KB

A phase II study of adoptive immunothera

A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma

✍ Daniel H. Palmer; Rachel S. Midgley; Noweeda Mirza; Elizabeth E. Torr; Forhad Ah 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB

This is a phase II clinical trial investigating the safety and efficacy of intravenous vaccination with mature autologous dendritic cells (DCs) pulsed ex vivo with a liver tumor cell line lysate (HepG2) in patients with advanced hepatocellular carcinoma (HCC). HCC is an attractive target for immunot